The management of periprosthetic infections in the future: a review of new forms of treatment.
The number of arthroplasties being undertaken is expected to grow year on year, and periprosthetic joint infections will be an increasing socioeconomic burden. The challenge to prevent and eradicate these infections has resulted in the emergence of several new strategies, which are discussed in this review. Cite this article: Bone Joint J 2015;97-B:1162-9.
University College London Hospitals, 235 Euston Road, London, NW1 2BU, UK.
D A
DA
George
University College London Hospitals, 235 Euston Road, London, NW1 2BU, UK.
V
V
Gant
University College London Hospitals, 235 Euston Road, London, NW1 2BU, UK.
F S
FS
Haddad
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D019643:Arthroplasty, Replacement / Q000379:methods / Q000639:trends*; D020099:Coated Materials, Biocompatible; D019468:Disease Management; D006801:Humans; D007595:Joint Prosthesis / Q000009:adverse effects*; D010778:Photochemotherapy / Q000379:methods; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible
Periprosthetic infections; Novel therapy; Future treatment; Emerging therapies